Abarelix (plenaxis).
Hogle
William P
WP
Cancer Center at University of Pittsburgh Medical Center-Passavant in Pennsylvania, USA. Hoglewp@ph.upmc.edu
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004347:Drug Interactions; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D006801:Humans; D008297:Male; D024802:Nurse's Role; D009842:Oligopeptides / Q000494:pharmacology / Q000627:therapeutic use*; D009859:Oncology Nursing / Q000379:methods; D010353:Patient Education as Topic; D018579:Patient Selection; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000451:nursing
D000970:Antineoplastic Agents; D009842:Oligopeptides; D007987:Gonadotropin-Releasing Hormone; C423508:abarelix